Latest Osteoclast Stories
UT Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.
Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth.
By analyzing biopsy specimens from patients with postmenopausal osteoporosis and primary hyperparathyroidism, investigators have begun to pay increasing attention to "reversal cells," which prepare for bone formation during bone remodeling.
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease.
New research in animals triggered by a combination of serendipity and counterintuitive thinking could point the way to treating fractures caused by rapid bone loss in people, including patients with metastatic cancers.
Researchers at the Institut de recherches cliniques de Montréal (IRCM), directed by Dr. Jean Vacher, identified a new gene that modulates bone mass and that could become a risk factor for developing osteoporosis.
New research shows that the Wnt receptor Frizzled-9 (Fzd9) promotes bone formation, providing a potential new target for the treatment of osteoporosis.
A gene from the measles virus plays a key role in the development of Paget's disease of bone, according to a team of researchers led by the University of Pittsburgh School of Medicine.
The "vegetable lamb" plant â€” once believed to bear fruit that ripened into a living baby sheep â€” produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease.
PUTEAUX, France, December 16 /PRNewswire/ -- - Studies Conducted at INRA-Agroparistech Laboratory Under Pr.
- A poem in which the author retracts something said in an earlier poem.